Volume : 09, Issue : 07, July – 2022



Authors :

Shilpa Suresh* , Dr. Subhash Chandran M P , Dr. Prashob G R , Sonam Sasi

Abstract :

Pens and autoinjectors are mainly used for the subcutaneous delivery of biopharmaceuticals, primarily for self-administration by the patient. The ability to self-inject has been the core driver for their development and made them such an important part of the world of drug delivery devices for more than 25 years. With the worldwide increase in diabetes as well as the trend towards biological drugs which cannot be administered orally, their importance continues to grow. This chapter provides an overview of the different types of injection devices as well as what the development of such a device entails. Firstly, the landscape of injection devices is presented including a brief review of the different primary containers around which the devices are designed. The different types of pens and autoinjectors are described in some detail before reviewing the development process. The development sections outline the applicable regulatory requirements, provide examples of useful development tools, and then describe the different steps involved in injection device development and industrialization.
Key words: Auto injector, The needleless Molly® trainer, Penny™ Adjustable Multi-Dose Injector.

Cite This Article:

Please cite this article in press Shilpa Suresh et al, Auto Injectors & Pen Injectors: A User-Centric Design Approach., Indo Am. J. P. Sci, 2022; 09(7).,

Number of Downloads : 10


1. Dou, Z., Eshraghi, J., Guo, T., Veilleux, J. C., Duffy, K. H., Shi, G. H., & Vlachos, P. P. (2020). Performance characterization of spring actuated auto injector devices for Emgality and Aimovig. Current Medical Research and Opinion, 36(8), 1343-1354.
2. EpiPen (epinephrine injection, USP) Auto-Injector and its Authorized Generic. https://www.epipen.com/en/. Accessed February 20, 2018.
3. Muck, A., Bebarta, V., Borys, D., & Morgan, D. (2007). Six Years of Acute Unintentional Epinephrine Digital Injections: Lack of Ischemia or Significant Systemic Effects. Academic Emergency Medicine, 14(5 Supplement 1). doi:10.1197/j.aem.2007.03.1267.
4. Fitzcharles-Bowe, C., Denkler, K., & Lalonde, D. (2006). Finger Injection with High-Dose (1:1,000) Epinephrine: Does it Cause Finger Necrosis and should it be Treated? Hand, 2(1), 5-11. doi:10.1007/s11552-006-9012-4.
5. Schintler, M. V., Arbab, E., Aberer, W., Spendel, S., & Scharnagl, E. (2005). Accidental perforating bone injury using the EpiPen autoinjection device. Allergy, 60(2), 259-260. doi:10.1111/j.1398- 9995.2004.00620.x
6. Dou, Z., Eshraghi, J., Guo, T., Veilleux, J. C., Duffy, K. H., Shi, G. H., & Vlachos, P. P. (2020). Performance characterization of spring actuated autoinjector devices for Emgality and Aimovig. Current Medical Research and Opinion, 36(8), 1343-1354.
7. Subcutaneous Drug Delivery Devices Market (By Product Type: Auto-Injectors, Pen Injectors, Prefilled Syringes, Wearable Injectors, and Needle-Free Injectors; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021–2030”. Precedence Research.
8. Badkar AV et al, “Subcutaneous Delivery of High-Dose/Volume Biologics: Current Status and Prospect for Future Advancements”. Drug Des Devel Ther, 2021, Vol 2021(15), pp 159–170.
9. Arga, M., Bakirtas, A., Catal, F., Derinoz, O., Harmanci, K., Razi, C. H., Turktas, I. (2011). Training of trainers on epinephrine autoinjector use. Pediatric Allergy and Immunology, 22(6), 590- 593. doi:10.1111/j.1399- 3038.2011.01143.x
10. Bakirtas, A., Arga, M., Catal, F., Derinoz, O., Demirsoy, M. S., & Turktas, I. (2011). Make-up of the epinephrine autoinjector: the effect on its use by untrained users. Pediatric Allergy and Immunology, 22(7), 729-733. doi:10.1111/j.1399- 3038.2011.01195.x
11. Arga, M., Bakirtas, A., Topal, E., Yilmaz, O., Karagol, I. H., Demirsoy, M. S., & Turktas, I. (2012). Effect of epinephrine autoinjector design on unintentional injection injury. Allergy and Asthma Proceedings, 33(6), 488-492. doi:10.2500/aap.2012.33.3609
12. Gosbee, L. L. (2004). Nuts! I Can’t Figure Out How to Use My Life-Saving Epinephrine Auto-Injector! The Joint Commission Journal on Quality and Safety, 30(4), 220-223. doi:10.1016/s1549-3741(04)30024-9
13. Kränke, B., Reiter, H., Kainz, J. T., & Arbab, E. (2011). How to improve the safety of adrenaline (epinephrine) autoinjectors. Journal of Allergy and Clinical Immunology, 127(6), 1645. doi:10.1016/j.jaci.2011.02.009
14. AUVI-Q | Home. About AUVI-Q | AUVI-Q. https://www.auvi-q.com/about-auviq/. Accessed February 20, 2018.
15. Mehr, S., Robinson, M. and Tang, M. (2007), Doctor – How do I use my EpiPen?. Pediatric Allergy and Immunology, 18: 448–452. doi:10.1111/j.1399- 3038.2007.00529.x
16. Gold, M. S., & Sainsbury, R. (2000). First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). Journal of Allergy and Clinical Immunology, 106(1), 171-176. doi:10.1067/mai.2000.10604.